Disc Medicine director Kevin Bitterman disposes of USD 4.36 million in common shares
IRON•Director reports common share sales
- Disc Medicine: Director Kevin Bitterman reported sales of 54,496 common shares from Sept. 1-3, 2026, at about $79.95-$80.98.
- Holdings tied to Atlas Venture funds fell to 319,778 shares, 312,989 shares, 13,445 shares across the three indirect positions.
